Therapeutic Program (Medications)

Fetter Health Care Network has been selected by the federal government to participate in a COVID-19 Therapeutics Program, which provides oral antiviral medication for eligible patients experiencing mild to moderate COVID-19 illness. Fetter will adhere to the Food and Drug Administration’s recommendations when assessing whether patients qualify to receive the medication.  To learn more about the available medications, select the link for the fact sheets below.

​

Available Medications:

​

Molnupiravir

​

​

Paxlovid

Fact Sheet for Molnupiravir
Fact Sheet for Paxlovid
med bottle.jpg

Back to COVID-19 Home 

white_footer_logov2.png.webp
HIT.png
BP_Participant.png.webp
footerNCQA_logo.png.webp
FQHC_logo.png.webp

Fetter Health Care Network is a Health Center Program grantee under 42 U.S.C. 254b, and a deemed Public Health Service employee under 42 U.S.C. 233(g)-(n). This health center receives HHS funding and has federal Public Health Service (PHS) deemed status with respect to certain health-related claims, including medical malpractice claims,

for itself and its covered individuals.